Clinical Trial: Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07686081) titled 'Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis' on June 30.

Brief Summary: A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Ponesimod (VSP-128) in patients with moderately to severely active ulcerative colitis

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC)

Intervention: DRUG: Ponesimod

Ponesimod administered orally once daily. Participants are randomized 2:1 to Ponesimod or placebo during a 16-week double-blind period. A 14-day titration is foll...